HELM INTELLIGENCEHIMS
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors may want to consider both the strong revenue growth and the concerns regarding profitability when evaluating Hims & Hers Health, Inc.
Hims & Hers Health, Inc. has a market capitalization of approximately $7.58B and a current stock price of $29.36, reflecting a 5.14% increase from the previous close of $27.93. The company reported a revenue growth of 59% year-over-year, although its EPS has seen a decline of 3.77%. Key metrics include a P/E ratio of 57.57 and a current ratio of 1.90.
Some investors cite Hims & Hers' impressive revenue growth of 59% year-over-year as a strong indicator of demand for its services. Additionally, the company's current ratio of 1.90 suggests a solid liquidity position.
Conversely, the decline in EPS by 3.77% year-over-year raises concerns about profitability. Furthermore, the P/E ratio of 57.57 may indicate that the stock is relatively expensive compared to its earnings.
Hold HIMS? See what it does to your whole book.
Connect a brokerage read-only and Helm shows HIMS next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See HIMS in my portfolioHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Hold HIMS? See what it does to your whole book.
Connect a brokerage read-only and Helm shows HIMS next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See HIMS in my portfolioHims & Hers Health, Inc. has a market capitalization of approximately $7.58B and a current stock price of $29.36, reflecting a 5.14% increase from the previous close of $27.93. The company reported a revenue growth of 59% year-over-year, although its EPS has seen a decline of 3.77%. Key metrics include a P/E ratio of 57.57 and a current ratio of 1.90.
Conversely, the decline in EPS by 3.77% year-over-year raises concerns about profitability. Furthermore, the P/E ratio of 57.57 may indicate that the stock is relatively expensive compared to its earnings.
Some investors cite Hims & Hers' impressive revenue growth of 59% year-over-year as a strong indicator of demand for its services. Additionally, the company's current ratio of 1.90 suggests a solid liquidity position.
Some investors cite Hims & Hers' impressive revenue growth of 59% year-over-year as a strong indicator of demand for its services. Additionally, the company's current ratio of 1.90 suggests a solid liquidity position. Conversely, the decline in EPS by 3.77% year-over-year raises concerns about profitability. Furthermore, the P/E ratio of 57.57 may indicate that the stock is relatively expensive compared to its earnings.
Hims & Hers Health, Inc. has a market capitalization of approximately $7.58B and a current stock price of $29.36, reflecting a 5.14% increase from the previous close of $27.93. The company reported a revenue growth of 59% year-over-year, although its EPS has seen a decline of 3.77%. Key metrics include a P/E ratio of 57.57 and a current ratio of 1.90.
Helm Terminal offers free AI-powered stock analysis for HIMS at helmterminal.dev/analyze/HIMS, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.